MVM Partners

Description

MVM Partners has been a life science investment fund for more than 25 years and invests broadly across the healthcare sector, including in specialty pharmaceuticals, medical technology, diagnostics, life science tools, consumer healthcare, veterinary medicine, contract manufacturing, healthcare services, and digital health. MVM has a global perspective on healthcare and maintains offices in Boston, London and the San Francisco Bay Area. Current MVM portfolio companies are headquartered in the US and Europe, and many have extensive operations in the Middle East and Asia. We’ve been alerted to fraudulent job offers impersonating MVM. Any recruiting emails related to MVM will only come from the @mvm.com domain. We do not ask for money, gift cards, crypto, or equipment purchases during hiring. To verify any message, email info@mvm.com. If you received a suspicious offer, please report it to the FTC (US) or Action Fraud (UK).

MVM Partners is a global life-sciences investment fund with over $1bn AUM that backs innovative product-stage healthcare companies — medical devices, specialty pharmaceuticals, diagnostics, and contract manufacturing — and has no mandate or track record in healthcare-services platform buyouts or dental practice acquisition.

MVM Partners is a life-sciences VC/growth-equity fund focused exclusively on product-stage companies — medical devices, pharmaceuticals, diagnostics, contract manufacturing, and digital health — with no evidence of healthcare-services platform buyouts or dental/DSO investments; their portfolio (CurvaFix, Nalu Medical, Avanzanite, etc.) confirms a pure product-company thesis, placing them in the excluded 'PRODUCT-focused VC' category.

enriched 2026-05-05

Financials